Lee JY - Search Results

1

Receptor interactions of Abbott-81988, a highly potent, non-peptide angiotensin-II antagonist selective for type-1 receptors.

Hancock AA, Buckner SA, Lee JY, Brune M, Morse PA, Oheim K, Warner RB, Winn M, Zydowsky TM, De B, et al. Hancock AA, et al. Among authors: lee jy. J Recept Res. 1994 May;14(3-4):229-49. doi: 10.3109/10799899409066034. J Recept Res. 1994. PMID: 8083867

2

Discovery of a novel class of orally active, non-peptide angiotensin II antagonists.

De B, Winn M, Zydowsky TM, Kerkman DJ, DeBernardis JF, Lee J, Buckner S, Warner R, Brune M, Hancock A, et al. De B, et al. J Med Chem. 1992 Oct 2;35(20):3714-7. doi: 10.1021/jm00098a018. J Med Chem. 1992. PMID: 1433184 No abstract available.

3

Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats.

Lee JY, Warner RB, Brune ME, Adler AL, Winn M, De B, Zydowsky TM, Opgenorth TJ, Kerkman DJ, DeBernardis JF. Lee JY, et al. Am J Hypertens. 1994 Nov;7(11):975-83. doi: 10.1093/ajh/7.11.975. Am J Hypertens. 1994. PMID: 7848624

4

Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.

Hancock AA, Buckner SA, Giardina WJ, Brune ME, Lee JY, Morse PA, Oheim KW, Stanisic DS, Warner RB, Kerkman DJ, et al. Hancock AA, et al. Among authors: lee jy. J Pharmacol Exp Ther. 1995 Mar;272(3):1160-9. J Pharmacol Exp Ther. 1995. PMID: 7891328

5

Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat.

Lee JY, Buckner SA, Brune ME, Warner RB, Winn M, De B, Zydowsky TM, Opgenorth TJ, Kerkman DJ, Debernardis JF. Lee JY, et al. J Pharmacol Exp Ther. 1994 Jan;268(1):427-33. J Pharmacol Exp Ther. 1994. PMID: 8301584

6

Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptors.

Hancock AA, Buckner SA, Lee JY, Brune M, Morse PA, Oheim K, Warner RB, Winn M, Zydowsky TM, De B, et al. Hancock AA, et al. Among authors: lee jy. Life Sci. 1993;53(11):929-37. doi: 10.1016/0024-3205(93)90445-9. Life Sci. 1993. PMID: 8366760

7

Antihypertensive activity of ABBOTT-81282, a nonpeptide angiotensin II antagonist, in the renal hypertensive rat.

Lee JY, Brune ME, Warner RB, Buckner SB, Winn M, De B, Zydowsky TM, Opgenorth TJ, Kerkman DJ, DeBernardis JF. Lee JY, et al. Pharmacology. 1993 Sep;47(3):176-87. doi: 10.1159/000139095. Pharmacology. 1993. PMID: 8415868

8

Orthostatic hypotension occurs following alpha 2-adrenoceptor blockade in chronic prazosin-pretreated conscious spontaneously hypertensive rats.

Lee JY, Brune ME, Warner RB, DeBernardis JF. Lee JY, et al. J Auton Pharmacol. 1992 Aug;12(4):191-204. doi: 10.1111/j.1474-8673.1992.tb00333.x. J Auton Pharmacol. 1992. PMID: 1355091

9

Calcium-induced vasocontractions after alpha-2 adrenergic receptor activation in the dog saphenous vein: comparison to calcium-induced contractions after potassium-depolarization.

Lee JY, Warner RB, Brune ME, DeBernardis JF. Lee JY, et al. Gen Pharmacol. 1990;21(5):647-54. doi: 10.1016/0306-3623(90)91012-g. Gen Pharmacol. 1990. PMID: 1980472

10

Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat.

Lee JY, Warner RB, Adler AL, Opgenorth TJ. Lee JY, et al. Pharmacology. 1994 Nov;49(5):319-24. doi: 10.1159/000139249. Pharmacology. 1994. PMID: 7862744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,878 results

Search Page

Filters